199 related articles for article (PubMed ID: 14293465)
21. TOPICAL TREATMENT OF RHEUMATOID ARTHRITIS WITH FLUOCINOLONE ACETONIDE UNDER OCCULSIVE DRESSING.
ALLANDER E; HELLGREN L
Acta Rheumatol Scand; 1964; 10():305-12. PubMed ID: 14237387
[No Abstract] [Full Text] [Related]
22. [TREATMENT OF PSORIATIC LESIONS WITH TOPICAL APPLICATION OF FLUOCINOLONE ACTONIDE CREAM (DERMALAR ) WITH OCCLUSIVE DRESSINGS].
KATZENELLENBOGEN I; FEUERMAN EJ
Harefuah; 1963 Nov; 65():316-20. PubMed ID: 14087553
[No Abstract] [Full Text] [Related]
23. Psoriasis treated with tropical fluocinolone acetonide and occlusive dressings.
STEVENSON CJ; WHITTINGHAM GE
Br Med J; 1963 Jun; 1(5343):1450-1. PubMed ID: 13984050
[No Abstract] [Full Text] [Related]
24. [FLUOCINOLONE IN DERMATOLOGY].
CORDERO AA
Prensa Med Argent; 1963 Apr; 50():1077-80. PubMed ID: 14089188
[No Abstract] [Full Text] [Related]
25. EFFECT OF TOPICAL FLUOROMETHOLONE ON INFECTED AND UNINFECTED DERMATOSES. A CLINICAL AND MICROBIOLOGICAL STUDY.
FRITSCH CJ; FRITSCH WC
Arch Dermatol; 1964 Dec; 90():604-13. PubMed ID: 14206867
[No Abstract] [Full Text] [Related]
26. Triamcinolone acetonide ointment and cream; combined local steroid application and occlusive dressing therapy in podiatric dermatoses.
PRENTICE H; BREZAK S
J Am Podiatry Assoc; 1963 Apr; 53():279-81. PubMed ID: 13986038
[No Abstract] [Full Text] [Related]
27. [Endocrine and metabolic effects of local corticotherapy].
Rimbaud P; Meynadier J
Ann Dermatol Syphiligr (Paris); 1968; 95(3):253-62. PubMed ID: 5697206
[No Abstract] [Full Text] [Related]
28. MANAGEMENT OF THE PSYCHOGENIC FACTORS IN DERMATOSES BY USE OF CHEMOTHERAPY.
SEGAEL A; ROGIN JR
Med Times; 1964 Feb; 92():113-6. PubMed ID: 14127053
[No Abstract] [Full Text] [Related]
29. FLUOCINOLONE ACETONIDE IN AN OINTMENT BASE: CLINICAL STUDIES IN SELECTED DERMATOSES.
SEIGERMAN H
Clin Med (Northfield); 1964 Jun; 71():1042-4. PubMed ID: 15446175
[No Abstract] [Full Text] [Related]
30. [New treatment trial under occlusive dressings of some dermatoses].
Colomb L; Dugois P; Amblard P
Lyon Med; 1966 Jan; 215(4):240-1. PubMed ID: 5905380
[No Abstract] [Full Text] [Related]
31. HISTOLOGICAL CHANGES IN PSORIASIS TREATED WITH TOPICAL FLUOCINOLONE AND OCCLUSION.
MCKENZIE AW
Br J Dermatol; 1963 Nov; 75():434-40. PubMed ID: 14072613
[No Abstract] [Full Text] [Related]
32. PECULIARITIES IN DERMATOLOGY. LICHENIFICATION, AN EXTENSIVE CASE OF LICHEN SIMPLEX CHRONICUS OF VIDAL-BROCQ.
KINGSLEY HJ
Cent Afr J Med; 1965 Jan; 11():16. PubMed ID: 14254091
[No Abstract] [Full Text] [Related]
33. [Occlusive therapy of dermatosis with fluocinolone acetonide].
Armentano E
Clin Ter; 1967 Jul; 42(2):141-6. PubMed ID: 5596412
[No Abstract] [Full Text] [Related]
34. WHAT'S NEW AROUND THE WORLD.
BURKS JW
Dermatol Trop Ecol Geogr; 1963; 19():40-8. PubMed ID: 14042845
[No Abstract] [Full Text] [Related]
35. [On the effectiveness of highly concentrated fluocinolone acetonide cream in various skin diseases].
Gebhardt R; Holzmann H
Med Welt; 1969 Mar; 9():484-8. PubMed ID: 5771355
[No Abstract] [Full Text] [Related]
36. TOPICAL FLUOCINOLONE WITH OCCLUSION IN PRETIBIAL MYXEDEMA.
JONES BE; WILLIAMS RM
Arch Dermatol; 1964 Sep; 90():305-6. PubMed ID: 14170604
[No Abstract] [Full Text] [Related]
37. [USE OF ARTIFICIAL FEVER IN THE TREATMENT OF SOME DERMATOSES].
STUDNICIN AA
Cesk Dermatol; 1964 Jul; 39():225-8. PubMed ID: 14180122
[No Abstract] [Full Text] [Related]
38. ATROPHIC STRIAE AFTER OCCLUSIVE CORTICOSTEROID THERAPY.
CHERNOSKY ME; KNOX JM
Arch Dermatol; 1964 Jul; 90():15-9. PubMed ID: 14149715
[No Abstract] [Full Text] [Related]
39. Fluocinolone acetonide 0.2 per cent cream--a co-operative clinical trial.
Marsden CW
Br J Dermatol; 1968 Sep; 80(9):614-7. PubMed ID: 4877599
[No Abstract] [Full Text] [Related]
40. SOME QUANTITATIVE FACTORS IN TOPICAL CORTICOSTEROID THERAPY.
SCHOLTZ JR; NELSON DH
Clin Pharmacol Ther; 1965; 6():498-509. PubMed ID: 14314974
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
